HISAMITSU PHARMACEUTICAL CO.,INC.
久光製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4530
FY2024 · 2025-02-28
| Gross margin | 58.5% |
| Operating margin | 12.1% |
| Net margin | 13.9% |
| Return on equity | 9.8% |
| Return on assets | 6.3% |
| Revenue growth (YoY) | 10.1% |
| EPS (basic) | ¥295.57 |
| EPS growth (YoY) | 62.7% |
| Current ratio | 4.32x |
| Equity ratio | 64.5% |
| Book value / share | ¥3,788.47 |
| Free cash flow | 5,138 M |